Search Results 181-190 of 15579 for TNF
... Tumor Necrosis Factor (TNF) therapy. A Study to Evaluate the Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy Jacksonville, FL.
... Tumor Necrosis Factor-Alpha Therapy (anti-TNF α) agent. -Effective contraception from screening, and for 36 weeks after the last dose of investigational ...
Exposure to more than 1 TNF-antagonist or primary failure to TNF antagonist therapy; History of or current chronic or recurrent infections; Subjects with ...
- Women who are pregnant or breastfeeding. - Patients undergoing concurrent treatment with agents targeting tumor necrosis factor alpha (TNF?) or IL-1 ...
immunosuppressants or anti-Tumor Necrosis Factor (TNF) agents (or other anti-inflammatory/anti-fibrotic treatment) received not later than 4 months prior to ...
* TNF-alpha inhibitors * IL-12/23 inhibitors * Anti-integrins * JAK inhibitors * OR * Non-response (primary failure), complete loss of response (secondary ...
Use of TNF antagonists;; Use of antagonists of IL-12 ± IL-23 (e.g., ustekinumab);; Immunization with a live/attenuated vaccine;; Use of anti-adhesion molecules ...
... tumor necrosis factor-alpha. Subsequent co-culture of the neuronal cells with mesenchymal stem cells alleviated those effects. The researchers believe that ...
... tumor necrosis factor-alpha in human epithelial tumor cells. J Cell Biochem. 1992 Feb; 48 (2):203-14. View PubMed; Marusic M, Bajzer Z, Freyer JP, Vuk ...
TNF alpha-induced hepatocyte apoptosis is associated with alterations of the cell cycle and decreased stem loop binding protein. Surgery. 2004 Jun; 135 (6): ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.